Home/ Stocks/ MBIO

Mustang Bio, Inc.

MBIO XNAS

$0.60 +0.02 (+3.04%) ▲ 15-min delayed

Open

$0.56

High

$0.65

Low

$0.56

Volume

73.5K

Market Cap

$4.36M

About Mustang Bio, Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 4 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-1,072,000	$-0.16
Q1 2026	$0	$-955,000	$-0.14
FY 2025	$0	$-1,921,000	$-0.39
Q3 2025	$0	$-468,000	$-0.07

Earnings & Analyst Ratings

Next Earnings: Thu, Nov 5, 2026

Calendar →

Related Market News

No specific coverage for MBIO yet. Check out our latest market news or earnings calendar.

Get MBIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Mustang Bio, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.